Anaphylactic reaction after rocuronium.
Brozovic
G
G
Kvolik
S
S
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000707:Anaphylaxis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D000732:Androstanols / Q000009:adverse effects*; D000768:Anesthesia, General; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D004280:Dobutamine / Q000627:therapeutic use; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D000077123:Rocuronium; D020521:Stroke / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D002583:Uterine Cervical Neoplasms / Q000601:surgery
D000318:Adrenergic beta-Agonists; D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D004280:Dobutamine; D000077123:Rocuronium